Pfizer’s Mylotarg ... after the FDA reapproved it in the aggressive blood cancer, acute myeloid leukaemia. The world’s first approved antibody-drug conjugate, where a targeted antibody ...

M.D., deputy director of the Division of Non-Malignant Hematology in the FDA’s Center for Drug Evaluation and Research. “This new treatment option highlights our continued efforts to improve the lives ...

Sanofi SNY and partner, Alnylam Pharmaceuticals ALNY, announced that the FDA has approved Qfitlia (fitusiran) as the first antithrombin-lowering (AT) therapy for routine prophylaxis to prevent ...

April 21, 2025 – The FDA just approved the popular drug Dupixent ... said in a news release from Sanofi, the drug's maker. Developed by Sanofi and Regeneron and first approved in 2017 ...

"Today's approval ... in the FDA's Center for Drug Evaluation and Research. "This new treatment option highlights our continued efforts to improve the lives of patients with hemophilia." ...